These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38264231)

  • 1. Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitus.
    Sakane N; Hirota Y; Yamamoto A; Miura J; Takaike H; Hoshina S; Toyoda M; Saito N; Hosoda K; Matsubara M; Tone A; Kawashima S; Sawaki H; Matsuda T; Domichi M; Suganuma A; Sakane S; Murata T
    Diabetol Int; 2024 Jan; 15(1):109-116. PubMed ID: 38264231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
    Rodbard D
    Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
    Oriot P; Hermans MP
    J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
    Krajnc M; Kravos Tramšek NA
    Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To Use or Not to Use a Self-monitoring of Blood Glucose System? Real-world Flash Glucose Monitoring Patterns Using a Cluster Analysis of the FGM-Japan Study.
    Sakane N; Hirota Y; Yamamoto A; Miura J; Takaike H; Hoshina S; Toyoda M; Saito N; Hosoda K; Matsubara M; Tone A; Kawashima S; Sawaki H; Matsuda T; Domichi M; Suganuma A; Sakane S; Murata T
    Intern Med; 2023 Sep; 62(18):2607-2615. PubMed ID: 36631091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time in Range in Children with Type 1 Diabetes before and during a Diabetes Camp-A Ceiling Effect?
    Nagl K; Bozic I; Berger G; Tauschmann M; Blauensteiner N; Weimann K; Mader JK; Rami-Merhar B
    Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of do-it-yourself real-time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial.
    Elbalshy MM; Styles S; Haszard JJ; Galland BC; Crocket H; Jefferies C; Wiltshire E; Tomlinson P; de Bock MI; Wheeler BJ
    Pediatr Diabetes; 2022 Jun; 23(4):480-488. PubMed ID: 35253331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of use and improvement in glycemic indices after initiating continuous glucose monitoring in real world: Data from Saudi Arabia.
    Alyusuf EY; Alharthi S; Alguwaihes AM; Jammah AA; Alfadda AA; Al-Sofiani ME
    Diabetes Metab Syndr; 2022 Feb; 16(2):102416. PubMed ID: 35150962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes.
    Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
    Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Control in Patients with Type 1 Diabetes: Comparison of Holidays versus Schooldays.
    Al Hayek A; Alwin Robert A; Almonea K; Al Dawish MA
    Curr Diabetes Rev; 2024 Jan; ():. PubMed ID: 38310482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study
    Préau Y; Galie S; Schaepelynck P; Armand M; Raccah D
    Sensors (Basel); 2021 Sep; 21(18):. PubMed ID: 34577338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
    Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
    Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study.
    Eliasson B; Allansson Kjölhede E; Salö S; Fabrin Nielsen N; Eeg-Olofsson K
    Diabetes Ther; 2024 Jun; 15(6):1301-1312. PubMed ID: 38598054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.
    Fuhri Snethlage CM; McDonald TJ; Oram RD; de Groen P; Rampanelli E; Schimmel AWM; Holleman F; Siegelaar S; Hoekstra J; Brouwer CB; Knop FK; Verchere CB; van Raalte DH; Roep BO; Nieuwdorp M; Hanssen NMJ
    Diabetes Care; 2024 Jul; 47(7):1114-1121. PubMed ID: 37535870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
    Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
    Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.